Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |